BCAL Diagnostics LimitedASX: BDX

Letter to Shareholders re Annual General Meeting

· Issued by BCAL Diagnostics Limited via ASX

Filed with ASX · · 1 page · English

Release

BCAL Diagnostics Limited ABN 51 142 051 223 Suite 506 Level 5 50 Clarence Street Sydney NSW 2000 T +61 407 983 270 W www.bcaldiagnostics.com E [email protected] 17 September 2026 ANNUAL GENERAL MEETING NOTICE AND PROXY FORM Dear Shareholder, The Annual General Meeting (Meeting) of...

BCAL Diagnostics Limited on 6ix

Story so far

Earlier from BCAL Diagnostics

Later from BCAL Diagnostics

All BCAL Diagnostics news releases